Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Shontelle Dodson"'
Autor:
Mitchell S. Steiner, David Cella, Vickie E. Baracos, Aminah Jatoi, William J. Evans, James T. Dalton, Shontelle Dodson
Publikováno v:
Annual Review of Medicine. 62:265-279
Cancer cachexia is a complex metabolic condition characterized by loss of skeletal muscle. Common clinical manifestations include muscle wasting, anemia, reduced caloric intake, and altered immune function, which contribute to increased disability, f
Publikováno v:
Journal of Clinical Oncology. 30:e19585-e19585
e19585 Background: Although cachexia has been defined as >5% weight loss, limited data exists on the prevention and treatment of muscle wasting prior to a patient becoming cachectic. Cancer induced muscle wasting can begin early in the course of a pa
Autor:
Mary Ann Johnston, Adrian S. Dobs, Mitchell S. Steiner, Ronald A. Morton, Shontelle Dodson, Michael L. Hancock
Publikováno v:
Journal of Clinical Oncology. 30:e19582-e19582
e19582 Background: Hypogonadism has been associated with weight loss and poor outcomes in cancer patients. Up to 50% of males with advanced cancer are hypogonadal at presentation or during the course of treatment. Wasting in cancer patients has also
Publikováno v:
Journal of Clinical Oncology. 29:9117-9117
9117 Background: Cancer cachexia causes muscle wasting and decline in physical function. Studies show that NSCLC patients with weight loss at diagnosis have worse treatment outcomes and shorter ove...
Autor:
G. Barnette, Mitchell S. Steiner, Shontelle Dodson, Mary Ann Johnston, Adrian S. Dobs, Michael L. Hancock
Publikováno v:
Journal of Clinical Oncology. 29:9022-9022
9022 Background: Cancer cachexia causes muscle wasting and leads to decline in physical function. NSCLC patients with weight loss at diagnosis are less able to tolerate chemotherapy, have worse out...
Autor:
K.G. Barnette, Michael L. Hancock, Shontelle Dodson, Mitchell S. Steiner, D. Rodriguez, Ronald A. Morton
Publikováno v:
Journal of Clinical Oncology. 28:9147-9147
9147 Background: Cancer cachexia is a catabolic muscle wasting condition that leads to a reduction in lean body mass (LBM). The associated changes not only affect patient's health, but also QOL. We...
Autor:
Mitchell S. Steiner, James T. Dalton, Shontelle Dodson, Kester G. Barnette, Michael L. Hancock, Casey E. Bohl, D. Rodriguez, Ronald A. Morton
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle
BACKGROUND: Cachexia, also known as muscle wasting, is a complex metabolic condition characterized by loss of skeletal muscle and a decline in physical function. Muscle wasting is associated with cancer, sarcopenia, chronic obstructive pulmonary dise